Ray Dalio Bridgewater Associates
Ray Dalio is the founder of Bridgewater Associates, one of the world’s largest hedge funds, known for its unique “principles-based” culture and systematic investment approach. Dalio’s investment philosophy emphasizes diversified portfolios, risk parity, and the importance of understanding economic cycles in shaping investment decisions. He has authored several books, including “Principles: Life & Work,” in which he details his management philosophies, personal experiences, and life lessons.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$148M |
| 2 |
Mondelez International
MDLZ
|
+$144M |
| 3 |
Johnson & Johnson
JNJ
|
+$64.3M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$53.4M |
| 5 |
Microsoft
MSFT
|
+$51.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$225M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$151M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$91.6M |
| 4 |
Walmart Inc
WMT
|
+$87.7M |
| 5 |
JPMorgan Chase
JPM
|
+$79.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 29.71% |
| 2 | Healthcare | 20.65% |
| 3 | Consumer Discretionary | 10.85% |
| 4 | Financials | 7.63% |
| 5 | Technology | 4.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Canadian Pacific Kansas City
CP
$80.5B
| $11.9M | 0.06% |
177,256
-57,705
| -25% | -$4.36M |
|
227
Aflac
AFL
$62.6B
| $11.9M | 0.06% |
211,027
-103,020
| -33% | -$6.06M |
|
|
EA
228
DELISTED
Electronic Arts
EA
| $11.6M | 0.06% |
100,665
+79,320
| +372% | +$10M |
|
229
Canadian National Railway
CNI
$76.6B
| $11.6M | 0.06% |
107,097
-17,827
| -14% | -$2.12M |
|
230
Chemed
CHE
$7.22B
| $11.6M | 0.06% |
26,595
+5,007
| +23% | +$2.41M |
|
231
Paychex
PAYX
$42.7B
| $11.5M | 0.06% |
102,734
+4,648
| +5% | +$576K |
|
232
Amdocs
DOX
$6.22B
| $11.5M | 0.06% |
144,991
+89,759
| +163% | +$7.6M |
|
233
Pinterest
PINS
$13.4B
| $11.5M | 0.06% |
493,655
-273,911
| -36% | -$6.01M |
|
234
Albertsons Companies
ACI
$5.83B
| $11.4M | 0.06% |
458,939
+65,701
| +17% | +$1.79M |
|
235
EQT Corp
EQT
$32.3B
| $11.4M | 0.06% |
279,887
+260,873
| +1,372% | +$11.3M |
|
236
Waste Management
WM
$91B
| $11.1M | 0.06% |
69,397
+7,769
| +13% | +$1.28M |
|
|
MASI
237
DELISTED
Masimo
MASI
| $11.1M | 0.06% |
78,634
-33,739
| -30% | -$4.93M |
|
238
General Dynamics
GD
$106B
| $11.1M | 0.06% |
52,307
-64,739
| -55% | -$14.6M |
|
239
Jabil
JBL
$35.8B
| $11.1M | 0.06% |
192,263
-57,189
| -23% | -$3.33M |
|
240
Penumbra
PEN
$12.8B
| $11.1M | 0.06% |
58,511
-576
| -1% | -$92.4K |
|
241
Verisk Analytics
VRSK
$25B
| $11M | 0.06% |
64,435
+15,354
| +31% | +$2.87M |
|
242
Aon
AON
$76B
| $11M | 0.06% |
40,987
+22,448
| +121% | +$6.35M |
|
243
Sarepta Therapeutics
SRPT
$1.77B
| $10.9M | 0.06% |
98,408
-27,110
| -22% | -$2.73M |
|
244
Acadia Healthcare
ACHC
$2.94B
| $10.8M | 0.05% |
138,515
-107
| -0.1% | -$8.55K |
|
245
Linde
LIN
$226B
| $10.7M | 0.05% |
39,759
-12,795
| -24% | -$3.67M |
|
246
LyondellBasell Industries
LYB
$19.2B
| $10.5M | 0.05% |
139,747
-176,664
| -56% | -$14.9M |
|
247
Teladoc Health
TDOC
$1.3B
| $10.5M | 0.05% |
413,500
-9,331
| -2% | -$327K |
|
248
West Pharmaceutical
WST
$24.9B
| $10.4M | 0.05% |
42,077
+18,921
| +82% | +$5.76M |
|
|
CVSA
249
Covista Inc
CVSA
$4.8B
| $10.3M | 0.05% |
283,597
+126,939
| +81% | +$4.85M |
|
250
SLM Corp
SLM
$5.15B
| $10.3M | 0.05% |
738,548
+162,486
| +28% | +$2.52M |
|
Similar funds
Ray Dalio's Q3 2022 Portfolio in Review
As of Q3 2022, Ray Dalio held 1,045 positions worth $19.8B, down 16% from $23.6B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ray Dalio withdrew a net $2.53B in Q3 2022, closing 179 positions and reducing 498 holdings. Its most notable exit was Medtronic, an estimated $225M position sold in full.
By sector, the portfolio is most concentrated in Consumer Staples at 30% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Ray Dalio opened a new position in Accenture worth $29.3M.
- Ray Dalio's largest Q3 2022 buy was Accenture: 113,811 shares worth $29.3M.
- Ray Dalio added most to Visa in Q3 2022, an estimated $148M increase.
- Ray Dalio's biggest Q3 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $151M.
- Ray Dalio fully exited Medtronic in Q3 2022, selling an estimated $225M.
- Ray Dalio's ten largest holdings make up 32% of its $19.8B portfolio in Q3 2022.
- Ray Dalio opened 60 new positions and closed 179 in Q3 2022.
- Ray Dalio's portfolio value fell 16% quarter-over-quarter to $19.8B.
Based on Bridgewater Associates's 13F filing for Q3 2022, filed 10 Nov 2022.